This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Academisch Ziekenhuis Leiden, Academisch Ziekenhuis Leiden (h.o.d.n. Lumc), Octoplus Technologies B.v.. Active years: 2010-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2010-2017
Title: Pieter Hiemstra: Innovator in Antimicrobial Peptides
Introduction
Pieter Hiemstra is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of antimicrobial peptides, with a focus on their applications in treating various infections. His innovative work has led to the development of two patents that showcase his expertise and dedication to advancing medical science.
Latest Patents
Pieter Hiemstra's latest patents include groundbreaking inventions related to antimicrobial peptides. The first patent focuses on antimicrobial peptides and their pharmaceutical compositions, which are designed for the treatment or prevention of microbial, bacterial, fungal, viral, and parasitic infections. The second patent involves antimicrobial peptides derived from CAP18, providing methods to exert antimicrobial effects in both prophylactic and therapeutic treatments of bacterial or fungal infections. These inventions highlight his commitment to addressing critical health challenges.
Career Highlights
Throughout his career, Pieter Hiemstra has worked with esteemed organizations, including Academisch Ziekenhuis Leiden (h.o.d.n. LUMC) and Octoplus Technologies B.V. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.
Collaborations
Pieter has collaborated with notable colleagues such as Jan Wouter Drijfhout and Petrus Hendricus Nibbering. These partnerships have further enriched his research and innovation efforts, leading to impactful developments in antimicrobial therapies.
Conclusion
Pieter Hiemstra's work in the field of antimicrobial peptides exemplifies his innovative spirit and dedication to improving healthcare. His patents and collaborations reflect a commitment to advancing medical science and addressing pressing health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile